Aagylur Capsule
Product Images NDC 70709-102

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Aagylur (NDC 70709-102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cycle Pharmaceuticals Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Formula)

FDA Label Image

Structure (Structure)

FDA Label Image

Fig1 (Figure1)

FDA Label Image

Container Label (Label)

Container Label (Label)
This text provides information about AAGYLUR™ capsules, each containing 250 mg of penicillamine. The capsules are meant for prescription use and come in a pack of 100 capsules. The recommended storage conditions are between 20° to 25°C. It also includes manufacturer details for Pharmaceutical International Inc. in Hunt Valley, Maryland, and indicates it is manufactured for Cycle Pharmaceuticals Ltd. based in Cambridge, UK. The text suggests referring to the package insert for complete prescribing information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.